Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic AntibodyAssociated Vasculitis

By K. de Groot, L. Harper, D. Jayne, Luis Felipe Flores Suárez, G. Gregorini, W. Gross, R. Luqmani, C. Pusey, N. Rasmussen, R. Sinico and 4 more. Annals of Internal Medicine, 2009

696 citations recorded by the source corpus.

Subfields: Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/6d35628ec4025b875cf2cc18eaf98de0d7921779

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Yates
2. R. Watts
3. B. Hellmich
4. I. Bajema
5. M. Cid
6. T. Hauser
7. B. Crestani
8. R. Luqmani

Citations in the corpus

• EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis (2016, background): “No difference was noted between the treatment arms in terms of time to remission or the proportion achieving remission at nine months (49).”